Hill Deirdre A, Linet Martha S, Black Peter M, Fine Howard A, Selker Robert G, Shapiro William R, Inskip Peter D
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.
Neuro Oncol. 2004 Oct;6(4):274-80. doi: 10.1215/S1152851704000109.
Relatively little is known about factors that contribute to the development of meningioma and vestibular schwannoma, two intracranial nervous system tumors. We evaluated the risk of these tumors in relation to family history of malignant or benign tumors. Incident cases of meningioma (n = 197) or schwannoma (n = 96) were identified at three U. S. referral hospitals between June 1994 and August 1998. Controls (n = 799) admitted to the same hospitals for nonmalignant conditions were matched to cases on age, sex, race/ethnicity, hospital, and proximity of residence to hospital. We found that risk of meningioma was increased among persons reporting a family history of a benign brain tumor (odds ratio [OR], 4.5; 95% confidence interval [CI], 1.0-21.0; n = 5) or melanoma (OR, 4.2; 95% CI, 1.2-15.0; n 5). A family history of breast cancer was associated with an elevated meningioma risk among participants aged 18 to 49 years (OR, 3.9; 95% CI, 1.4-11.0; n = 8) but a reduced risk among older respondents (OR, 0.2; 95% CI, 0.1-0.7; n = 3). Family history of cancer did not differ between schwannoma cases and controls, although the statistical power to detect associations was limited. Some relative risk estimates were based on a small number of observations and may have arisen by chance. Inheritance of predisposing genes, shared environmental factors, or both within families with a history of benign brain tumors, melanoma, or possibly breast cancer may be related to altered meningioma risk.
对于导致脑膜瘤和前庭神经鞘瘤这两种颅内神经系统肿瘤发生的因素,人们了解相对较少。我们评估了这些肿瘤与恶性或良性肿瘤家族史相关的风险。1994年6月至1998年8月期间,在美国的三家转诊医院确定了脑膜瘤(n = 197)或神经鞘瘤(n = 96)的发病病例。因非恶性疾病入住同一家医院的对照组(n = 799)在年龄、性别、种族/民族、医院以及居住地点与医院的距离方面与病例进行了匹配。我们发现,报告有良性脑肿瘤家族史的人患脑膜瘤的风险增加(优势比[OR],4.5;95%置信区间[CI],1.0 - 21.0;n = 5)或有黑色素瘤家族史的人患脑膜瘤的风险增加(OR = 4.2;95% CI,1.2 - 15.0;n = 5)。乳腺癌家族史与18至49岁参与者患脑膜瘤风险升高相关(OR = 3.9;95% CI,1.4 - 11.0;n = 8),但在年龄较大的受访者中风险降低(OR = 0.2;95% CI,0.1 - 0.7;n = 3)。神经鞘瘤病例和对照组之间的癌症家族史没有差异,尽管检测关联的统计效力有限。一些相对风险估计基于少量观察结果,可能是偶然出现的。在有良性脑肿瘤、黑色素瘤或可能有乳腺癌家族史的家庭中,易感基因的遗传、共同的环境因素或两者可能与脑膜瘤风险改变有关。